NZ319639A - membrane protein p76 of helicobacter pylori - Google Patents

membrane protein p76 of helicobacter pylori

Info

Publication number
NZ319639A
NZ319639A NZ319639A NZ31963996A NZ319639A NZ 319639 A NZ319639 A NZ 319639A NZ 319639 A NZ319639 A NZ 319639A NZ 31963996 A NZ31963996 A NZ 31963996A NZ 319639 A NZ319639 A NZ 319639A
Authority
NZ
New Zealand
Prior art keywords
helicobacter pylori
protein
membrane protein
helicobacter
pylori
Prior art date
Application number
NZ319639A
Inventor
Ling Lissolo
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of NZ319639A publication Critical patent/NZ319639A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to a protein of Helicobacter pylori in a substantially purified form, susceptible of being obtained from a membrane fraction of Helicobacter pylori and of which the molecular weight after electrophoresis on polyacrylamide gel 10 % in the presence of SDS is approximately of 76 kD. Also claimed is a polypeptide derived by mutation or fragmentation from the above protein, a pharmaceutical composition for the prevention of a H. pylori infection, monospecific antibody capable of recognizing a protein above, and a diagnostic method which makes it possible to detect the presence of Helicobacter in a biological sample.
NZ319639A 1995-10-04 1996-10-04 membrane protein p76 of helicobacter pylori NZ319639A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511891A FR2739623B1 (en) 1995-10-04 1995-10-04 NEW MEMBRANE PROTEIN P76 FROM HELICOBACTER PYLORI
PCT/FR1996/001551 WO1997012908A1 (en) 1995-10-04 1996-10-04 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI

Publications (1)

Publication Number Publication Date
NZ319639A true NZ319639A (en) 1999-11-29

Family

ID=9483403

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ319639A NZ319639A (en) 1995-10-04 1996-10-04 membrane protein p76 of helicobacter pylori

Country Status (10)

Country Link
EP (1) EP0797586A1 (en)
JP (1) JPH11505267A (en)
CN (1) CN1151172C (en)
AU (1) AU723885B2 (en)
CA (1) CA2206708A1 (en)
FR (1) FR2739623B1 (en)
HU (1) HUP9900427A3 (en)
NO (1) NO972531L (en)
NZ (1) NZ319639A (en)
WO (1) WO1997012908A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ333250A (en) * 1996-06-10 2000-05-26 Thomas Boren Helicobacter pylori blood group antigen binding adhesion protein
DE19630390A1 (en) * 1996-07-26 1998-01-29 Chiron Behring Gmbh & Co Proteins, in particular membrane proteins from Helicobacter pylori, their production and use
AU750792B2 (en) * 1997-04-01 2002-07-25 Human Genome Sciences, Inc. 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules
JP3869556B2 (en) * 1998-06-15 2007-01-17 勇 近藤 Helicobacter pylori-derived antigen and method for diagnosing Helicobacter pylori infection using the same
WO2000000614A2 (en) * 1998-06-26 2000-01-06 American Cyanamid Company NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI)
JP5250812B2 (en) * 2006-04-27 2013-07-31 国立大学法人富山大学 A novel antigen derived from Helicobacter pylori, an antigen composition, and a method for detecting an antibody against H. pylori.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (en) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen preparation for the detection of H. pylori

Also Published As

Publication number Publication date
FR2739623A1 (en) 1997-04-11
NO972531L (en) 1997-07-30
NO972531D0 (en) 1997-06-03
HUP9900427A3 (en) 2001-03-28
JPH11505267A (en) 1999-05-18
AU723885B2 (en) 2000-09-07
AU7220296A (en) 1997-04-28
WO1997012908A1 (en) 1997-04-10
HUP9900427A2 (en) 1999-05-28
CN1173876A (en) 1998-02-18
CN1151172C (en) 2004-05-26
MX9704110A (en) 1998-07-31
CA2206708A1 (en) 1997-04-10
FR2739623B1 (en) 1997-12-05
EP0797586A1 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
Matsuda et al. Isolation and purification of two antigenically active," complimentary" polypeptide fragments of tetanus neurotoxin
DE69333802T8 (en) OUTER MEMBRANE PROTEIN FROM HAEMOPHILUS
Snow et al. The T8 antigen is a multimeric complex of two distinct subunits on human thymocytes but consists of homomultimeric forms on peripheral blood T lymphocytes.
PT93910A (en) A product for the preparation of a blood protein by means of a blood cell
ES557358A0 (en) A METHOD FOR THE DETECTION OF SPECIFIC ANTIBODIES OF A LAV VIRUS IN A BIOLOGICAL FLUID.
CA2290485A1 (en) Method for the production of non-immunogenic proteins
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
DE68916932D1 (en) ANTIMICROBIAL PEPTIDES, COMPOSITIONS CONTAINING THEM AND USES THEREOF.
MX9708791A (en) Ataxia-telangiectasia gene and its genomic organization.
WO1998055606A3 (en) Lactoferrin receptor genes of moraxella
FR2660757B1 (en) METHOD OF IDENTIFYING OR DETERMINING PROTEINS AND APPLICATIONS.
IL105769A0 (en) Immobilized buffered gels and membranes of hydroxy group-containing polymers
EP0379549A4 (en) Endotoxin binding protein and uses thereof
NZ319639A (en) membrane protein p76 of helicobacter pylori
Adlersberg et al. Repetitive hinge region sequences in human IgG3: isolation of an 11,000-dalton fragment.
Hessel On the structure of the COOH-terminal part of the A α chain of human fibrinogen
DE3884316D1 (en) Synthetic peptides, antibodies directed against them and their use.
FR2692282B1 (en) CLONING OF THE GENE ENCODING THE PROTEIN GP28.5 OF T. GONDII; PEPTIDE FRAGMENTS FROM SUCH PROTEIN AND THEIR APPLICATIONS.
ATE356831T1 (en) NEW GALANIN RECEPTOR
Joubert et al. Purification, some properties and the primary structures of three reduced and S-carboxymethylated toxins (CM-5, CM-6 and CM-10a) from Naje haje haje (Egyptian cobra) venom
HUP9900498A2 (en) Novel membrane proteins of helicobacter pylori
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2
IT1284870B1 (en) PEPTIDES OF THE TLP COMPLEXES FROM CARCINOMIS OF THE UROGENITAL SYSTEM AND ANTIBODIES DIRECT AGAINST THEM
CA2329144A1 (en) New peptide fragments for protein purification
DE69631624D1 (en) ANTIBODIES AGAINST HUMAN RESTRICTIN

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)